Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties

Ablation outcome post a high second ablative dose of radioactive iodine (I131) in patients with papillary thyroid cancer

Shereen Wagieh, Khalid Salman, Sherif El Refaie, Maha Abd El- Kareem, Yasser Mohammad and Manal Al-Ezzi
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1859;
Shereen Wagieh
1Nuclear Medicine, King Abdulla Medical City, Jeddah, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Khalid Salman
1Nuclear Medicine, King Abdulla Medical City, Jeddah, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sherif El Refaie
2Nuclear Medicine, Cairo University, Cairo, Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maha Abd El- Kareem
2Nuclear Medicine, Cairo University, Cairo, Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasser Mohammad
2Nuclear Medicine, Cairo University, Cairo, Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manal Al-Ezzi
1Nuclear Medicine, King Abdulla Medical City, Jeddah, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 54 no. supplement 2 1859

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2013

Author Information

  1. Shereen Wagieh1,
  2. Khalid Salman1,
  3. Sherif El Refaie2,
  4. Maha Abd El- Kareem2,
  5. Yasser Mohammad2 and
  6. Manal Al-Ezzi1
  1. 1Nuclear Medicine, King Abdulla Medical City, Jeddah, Saudi Arabia
  2. 2Nuclear Medicine, Cairo University, Cairo, Egypt

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014800
Dec 2014100
Jan 2015800
Feb 20151700
Mar 20151000
Apr 2015900
May 2015100
Jun 2015300
Jul 2015400
Aug 2015100
Sep 20151700
Oct 2015100
Nov 2015600
Jan 2016300
Feb 2016100
Mar 2016800
Apr 2016800
May 2016100
Jun 2016300
Jul 2016100
Aug 2016400
Sep 2016500
Oct 2016300
Nov 2016100
Dec 2016200
Jan 2017400
Feb 2017400
Mar 2017300
Apr 2017300
May 2017400
Jun 2017600
Jul 2017500
Aug 2017100
Sep 2017200
Oct 2017400
Nov 2017300
Dec 2017500
Jan 2018100
Feb 2018200
Mar 2018200
Jun 2018100
Aug 2018400
Sep 2018300
Oct 2018200
Nov 2018500
Dec 2018400
Jan 2019300
Feb 2019100
Mar 2019700
May 2019100
Jul 2019500
Aug 2019200
Nov 2019100
Dec 2019200
Mar 2020400
Apr 2020300
Aug 2020500
Sep 2020100
Oct 2020100
Nov 2020300
Dec 2020100
Jan 2021100
Feb 2021900
Mar 2021700
Apr 2021700
May 20211200
Jun 2021900
Jul 20215600
Aug 202113900
Sep 2021400
Oct 2021200
Nov 20213000
Dec 2021700
Jan 2022400
Feb 2022200
Mar 2022300
Apr 2022100
May 2022400
Jun 2022200
Jul 2022100
Aug 2022100
Sep 2022400
Oct 2022200
Nov 2022300
Dec 2022300
Feb 2023100
Mar 2023600
Apr 2023100
May 2023700
Jun 2023400
Jul 2023300
Aug 2023200
Sep 2023200
Oct 20231100
Nov 2023500
Dec 2023200
Jan 2024600
Feb 2024300
Mar 2024300
Apr 2024700
May 2024400
Jun 2024600
Jul 20245900
Aug 20244900
Sep 2024500
Oct 2024700
Nov 20241100
Dec 20241100
Jan 20251200
Feb 20251300
Mar 2025900
Apr 20252000
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ablation outcome post a high second ablative dose of radioactive iodine (I131) in patients with papillary thyroid cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Ablation outcome post a high second ablative dose of radioactive iodine (I131) in patients with papillary thyroid cancer
Shereen Wagieh, Khalid Salman, Sherif El Refaie, Maha Abd El- Kareem, Yasser Mohammad, Manal Al-Ezzi
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1859;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Ablation outcome post a high second ablative dose of radioactive iodine (I131) in patients with papillary thyroid cancer
Shereen Wagieh, Khalid Salman, Sherif El Refaie, Maha Abd El- Kareem, Yasser Mohammad, Manal Al-Ezzi
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1859;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties

  • Exploring variations and utility of FDG- and NaF PET/CT in rheumatoid arthritis and osteoarthritis
  • Application of Lung perfusion only scan combined with SPECT/CT for the post-treatment evaluation of massive and sub-massive pulmonary embolism in the age of covid-19 pandemic: case presentation and literature review
  • Can FDG PET/CT imaging have a role in clinical cases of Dermatomyositis?
Show more General Clinical Specialties

MTA II: Endocrine/Neuroendocrine Posters

  • Functional imaging in paragangliomas with 68Ga-DOTA-TOC PET/CT and 123I-MIBG SPECT/CT imaging
  • The diagnostic value of dual-phase 99mTc-MIBI scintigraphy combined with SPECT/CT for primary hyperparathyroidism
  • Hypothyreosis induced myopathia in patients with DTC undergoing radioiodine treatment
Show more MTA II: Endocrine/Neuroendocrine Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire